Abstract Aims Implantable cardioverter defibrillators (ICDs) have shown to reduce all-cause
mortality in heart failure patients. In SCD-HeFT study, ICDs were programmed with a …

Ventricular tachycardia remains a difficult problem in spite of all the recent advances. Anti-
arrhythmic drugs continue to fail in more and more trials, and it is unlikely that we will have …

Background: The recently published Ventricular Arrhythmia Suppression Trial (VAST) found
no effect of rate‐smoothing (RS) algorithm on frequency of ventricular tachycardia (VT) …

Background Antitachycardia pacing (ATP) is a programmable therapy in implantable cardiac
defibrillator (ICD) devices that has been demonstrated to effectively reduce the need for …

When incorporated into tiered therapy implantable cardioverter defibrillators (ICDs),
antitachycardia pacing (ATP) techniques have proved useful for termination of sustained …

Antitachycardia pacemakers and implantable cardioverter defibrillators (ICD) were
implanted in 14 patients to control recurrent hemodynamically stable ventricular tachycardia …

Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …

The main purpose of ICDs is to abort sudden death by delivering therapy at the moment of
tachycardia. Shocks accomplish this goal but are painful. Alternatively antitachycardia …

Background Cardiac resynchronization therapy defibrillator can terminate ventricular
tachycardia (VT) and fast VT (FVT) via antitachycardia pacing (ATP). Objectives We …

Predischarge testing of implantable cardioverter-defibrillators is often used to tailor
antitachycardia pacing algorithms based on the response of induced ventricular tachycardia …